REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·Jul 28 at 05:06 AMGSK-1.22%03692-0.49%
HISOAR released its performance for the first half of the year, with a net profit attributable to the parent company of 14.0937 million yuan, a decrease of 63.01%Zhitong·Aug 29, 2025 at 04:43 AM002099+0.37%
A-share weight loss drug concept stocks continued to weaken in the afternoon, Menovo hit the limit down, Medicilon and Kanion Pharmaceutical fell over 7%, SDKX and HISOAR had the largest declinesWallstreetcn·Aug 28, 2025 at 12:16 AM603538+3.04%600557+1.42%
HISOAR: The market holds an overall optimistic attitude towards the price recovery of Peinan productsZhitong·Jul 11, 2025 at 01:10 AM002099+0.37%
Innovative drugs and CRO concept stocks strengthen again, Sunshine Guojian Pharmaceutical rises over 10%Zhitong·May 26, 2025 at 09:00 PM002099+0.37%688336+3.61%
The three major indices of A-shares in Shanghai and Shenzhen fell, with the ChiNext dropping 1% for the entire day, while pharmaceutical stocks rose against the trendAASTOCKS·May 22, 2025 at 02:00 AM002365+0.16%002099+0.37%
The innovative drug concept continues to strengthen, Sunshine Guojian Pharmaceutical has achieved 4 consecutive limit-upsZhitong·May 21, 2025 at 09:16 PM688336+3.61%002099+0.37%
HISOAR plans to spend between 150 million and 300 million yuan to repurchase sharesZhitong·Apr 9, 2025 at 08:19 AM002099+0.37%
HISOAR: The raw material drug of Diquafosol Sodium has obtained the drug registration certificate for raw materials in South KoreaZhitong·Feb 6, 2025 at 01:47 AM002099+0.37%
HISOAR issued a profit warning, expecting a net loss of 250 million to 350 million yuan in 2024Zhitong·Jan 21, 2025 at 06:40 AM002099+0.37%
